· 5% after one year
· 14% after two years
· 22% after three years
· 38% after five years
· 57% after 10 years, and
· More than 80% after 20 years of observation
At best, roughly comparing these two different studies, HDIT/ACST doesn’t seem to be any better than “placebo“, at least as far as I understand it.
Other comments or observations anyone?
Why?Would need to know what the classification of MS the patients int the 2nd study had to compare the two
Shayk wrote:RainerWhy?Would need to know what the classification of MS the patients int the 2nd study had to compare the two
Shayk wrote: I do think that resolution of inflammation can bring dramatic improvements, I'm less certain that it stops disease progression, which is what I tend to be most concerned about.
spiff wrote:These results are not what someone with PPMs wants to hear. I was DX'd ten years ago and have heard the same story over and overagain. Isn't it about time to take a different approach? From what I can see it's the same thing over and over with different results expected each time. How can anyone ever solve the problem when the cause is unknown?
Find the cause/find the cure.
Users browsing this forum: No registered users